Pharmacotherapy Risks in Rare Genetic Diseases: Cross‐Referencing ACMG Secondary Findings v3.2 List With Clinical Databases

Documenti analoghi

• Collaboration as a Catalyst for Advancing Rare Disease Research: The Experience of the Rare Diseases Clinical Research Network
  di: Mirna Chehade, et al.
  Pubblicazione: (2026)
• Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists
  di: Mariam A. Ahmed, et al.
  Pubblicazione: (2025)
• Anti‐Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea
  di: Anish Preshy, et al.
  Pubblicazione: (2026)
• Cross‐Reactive NSAID Hypersensitivity: Clinical Findings From Aspirin Provocation and Alternative Drug Challenge Testing
  di: Young‐Il Koh, et al.
  Pubblicazione: (2025)
• Development and Initial Use of a New Inflammatory Bowel Disease Clinical Database Integrating Both Eastern and Western Clinical Characteristics
  di: Jingshuang Yan, et al.
  Pubblicazione: (2025)